E. Burmeister Getz

Between‐Batch Pharmacokinetic Variability Inflates Type I Error Rate in Conventional Bioequivalence Trials: A Randomized Advair Diskus Clinical Trial

B. Jones, J. Mielke, L. Benet, 2016, Clinical pharmacology and therapeutics.

Batch Selection via In Vitro/In Vivo Correlation in Pharmacokinetic Bioequivalence Testing

L. Benet, B. Jones, K. Carroll, 2021, AAPS PharmSciTech.

Performance of Multiple-Batch Approaches to Pharmacokinetic Bioequivalence Testing for Orally Inhaled Drug Products with Batch-to-Batch Variability

K. Carroll, Beth Morgan, S. Lyapustina, 2021, AAPS PharmSciTech.

Batch‐to‐batch pharmacokinetic variability confounds current bioequivalence regulations: A dry powder inhaler randomized clinical trial

B. Jones, B Jones, E Burmeister Getz, 2016, Clinical pharmacology and therapeutics.

Performance of the Population Bioequivalence (PBE) Statistical Test with Impactor Sized Mass Data

G. Långström, D. Christopher, Beth Morgan, 2019, AAPS PharmSciTech.

Performance of the Population Bioequivalence (PBE) Statistical Test Using an IPAC-RS Database of Delivered Dose from Metered Dose Inhalers

G. Långström, D. Christopher, Beth Morgan, 2018, AAPS PharmSciTech.

Batch‐to‐Batch and Within‐Subject Variability: What Do We Know and How Do These Variabilities Affect Clinical Pharmacology and Bioequivalence?

Leslie Z Benet, L. Benet, K. Carroll, 2019, Clinical pharmacology and therapeutics.

Evaluation of a Scenario in Which Estimates of Bioequivalence Are Biased and a Proposed Solution: tlast (Common)

D. Fisher, W. Kramer, E. Burmeister Getz, 2015, Journal of clinical pharmacology.